Table 2.
Comparison between acquired UFF group and stable patients (categorical data as number (percentage) compared by Fisher's exact test; continuous data presented as median (25%–75% interquartile range), compared by Mann Whitney U-test); Δ Ca125 is the variation between last evaluation in the followup and baseline effluent CA125 U/min levels.
| Acquired UFF | Stable group | P | |
|---|---|---|---|
| N = 7 | N = 108 | ||
| Sex (male) (N; %) | 5 (71.4%) | 39 (36.1%) | 0.104 |
| Diabetes (N; %) | 0 (0%) | 22 (20.4%) | 0.343 |
| Age | 39 (34–45) | 48 (35–60) | 0.179 |
| Comorbidity score (≥2) | 2 (28.5%) | 28 (25.9%) | 0.203 |
| RRT time (months) | 77 (13–147) | 0 (0–33) | 0.003 |
| Baseline GFR mL/mn | 0 (0–3.6) | 5.1 (1.37–7.4) | 0.009 |
| APD (Yes) | 5 (71.4%) | 61 (56.5%) | 0.697 |
| Peritonitis (Yes) | 7 (100%) | 61 (56.5%) | 0.040 |
| Peritonitis (n) | 3 (1–4) | 1 (0–2) | 0.008 |
| PET parameters | |||
| D/P creatinine | 0.78 (0.75–0.94) | 0.71 (0.64–0.81) | 0.037 |
| D/D0 glucose | 0.24 (0.18–0.30) | 0.30 (0.30–0.34) | 0.021 |
| PET drainage | 2300 (2250–2400) | 2800 (2600–2900) | <0.0001 |
| D/P Na 60 | 0.92 (0.88–0.95) | 0,88 (0.85–0.89) | 0.007 |
| Dip Na | 0.028 (−0.007–0.054] | 0.048 (0.021–0.071) | 0.16 |
| Ca125 U/min | 23 (10–28) | 163 (86–227) | <0.0001 |
| Δ Ca125 | −52 (−79–−13) | 0 (−29–53) | 0.004 |